You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

hypopharyngeal cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Larynx Cancer, Hypopharyngeal Cancer Trial in Shanghai (procedure, radiation, drug)

Recruiting
  • Larynx Cancer
  • Hypopharyngeal Cancer
  • Surgery
  • +2 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Sep 9, 2023

The Voice asTool to Detect Recurrence of Laryngeal and

Not yet recruiting
  • Laryngeal Cancer
  • Hypopharyngeal Cancer
  • Voice recording, ENT (Ear, Nose and Throat) examination including transnasal fiberendoscopy, and VHI-30-questionnaire
  • Bern, Switzerland
    Department of Oto-Rhino-Laryngology, Head and Neck Surgery, Inse
May 30, 2023

Hypopharyngeal Cancer Trial (Cisplatin/Nedaplatin, albumin paclitaxel)

Not yet recruiting
  • Hypopharyngeal Cancer
  • Cisplatin/Nedaplatin, albumin paclitaxel
  • (no location specified)
May 5, 2023

Locally Advanced Hypopharyngeal Carcinoma Trial in Shanghai (drug, procedure, radiation)

Not yet recruiting
  • Locally Advanced Hypopharyngeal Carcinoma
  • three cycles (toripalimab + cetuximab + platinum)
  • +2 more
  • Shanghai, Shanghai, China
    Eye & ENT Hospital of Fudan University
Nov 22, 2023

Squamous Cell Carcinoma of the Larynx, Squamous Cell Carcinoma of the Hypopharynx Trial in Rotterdam (CRGD-ZW800-1)

Not yet recruiting
  • Squamous Cell Carcinoma of the Larynx
  • Squamous Cell Carcinoma of the Hypopharynx
  • Rotterdam, Zuid-Holland, Netherlands
    Erasmus Medical Center
Feb 21, 2023

Laryngeal Cancer, Hypopharyngeal Cancer Trial in Shanghai (Toripalimab)

Recruiting
  • Laryngeal Cancer
  • Hypopharyngeal Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jun 12, 2022

Immune Biomarker Study for Head and Neck Cancer

Recruiting
  • Head and Neck Cancer
  • +4 more
  • Sampling
  • Erlangen, Bavaria, Germany
  • +2 more
Jan 23, 2023

Hypopharyngeal Cancer, Immunotherapy, Induction Chemo Trial in Guangzhou (Camrelizumab)

Recruiting
  • Hypopharyngeal Cancer
  • +2 more
  • Guangzhou, Guangdong, China
    The First Affiliated Hospital of Sun Yat-sen University
Aug 14, 2021

Squamous Cell Carcinoma of Head and Neck, Hypopharyngeal Squamous Cell Carcinoma, Laryngeal Squamous Cell Carcinoma Stage III

Not yet recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • +11 more
  • KEYTRUDA®
  • (no location specified)
Nov 17, 2023

Laryngeal Disease, Laryngeal Lesions, Hypopharyngeal Lesions Trial in Ostrava, Hradec Králové (Enhanced contact endoscopy,

Recruiting
  • Laryngeal Disease
  • +6 more
  • Enhanced contact endoscopy
  • +2 more
  • Ostrava, Moravian-Silesian Region, Czechia
  • +1 more
Jun 29, 2021

Caregiver, Malignant Head and Neck Tumor, Paranasal Sinus Squamous Cell Carcinoma Trial in Winston-Salem (Communication

Completed
Has Results
  • Caregiver
  • +37 more
  • Communication Intervention
  • +5 more
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Dec 14, 2022

Hypopharyngeal Carcinoma Trial in China (drug, radiation, procedure)

Not yet recruiting
  • Hypopharyngeal Carcinoma
  • Beijing, Beijing, China
  • +3 more
Aug 9, 2022

Blood Tests and Questionnaires in Studying Adherence to

Recruiting
  • Carcinoma of Unknown Primary
  • +30 more
  • Biospecimen Collection
  • Questionnaire Administration
  • Houston, Texas
    M D Anderson Cancer Center
Dec 12, 2022

Carcinoma, Squamous Cell of Head and Neck, HPV Positive Oropharyngeal Squamous Cell Carcinoma, Hypopharyngeal Cancer Trial in

Completed
  • Carcinoma, Squamous Cell of Head and Neck
  • +5 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Jan 24, 2022

Head and Neck Squamous Cell Carcinoma, Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Hypopharyngeal Squamous Cell

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +23 more
  • Biospecimen Collection
  • +2 more
  • Los Angeles, California
  • +1 more
Jul 7, 2022

Laryngeal Cancer, Hypopharynx Cancer, Laryngeal Tumors Trial in Shanghai (chemo TP regimen combined with Toripalimab)

Recruiting
  • Laryngeal Cancer
  • +2 more
  • chemotherapy TP regimen combined with Toripalimab
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jan 2, 2022

Clinical Stage III Human Papillomavirus (HPV)-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage IV

Recruiting
  • Clinical Stage III Human Papillomavirus (HPV)-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • +28 more
  • San Francisco, California
    University of California, San Francisco
Dec 16, 2022

Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Metastatic Head and Neck Squamous Cell Carcinoma,

Recruiting
  • Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • +24 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
May 18, 2022

Active, not recruiting
  • Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7
  • +8 more
  • Cetuximab
  • +3 more
  • Pittsburgh, Pennsylvania
    University of Pittsburgh Cancer Institute (UPCI)
Jan 26, 2023

Hypopharyngeal Cancer Trial in Beijing (Induction CT+ CRT group, Concurrent CRT group)

Recruiting
  • Hypopharyngeal Cancer
  • Induction CT+ CRT group
  • Concurrent CRT group
  • Beijing, China
    Cancer hospital, Chinese Academy of Medical Sciences
Jan 28, 2021

Head and Neck Carcinoma of Unknown Primary, Locally Advanced Head and Neck Squamous Cell Carcinoma, Locally Advanced

Recruiting
  • Head and Neck Carcinoma of Unknown Primary
  • +24 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Aug 6, 2022

Advanced Head and Neck Squamous Cell Carcinoma, Advanced Hypopharyngeal Squamous Cell Carcinoma, Advanced Laryngeal Squamous

Suspended
  • Advanced Head and Neck Squamous Cell Carcinoma
  • +17 more
  • Gilbert, Arizona
  • +19 more
Dec 31, 2022

Locoregionally Advanced Laryngo-hypopharyngeal Squamous Cell Cancer Trial in Shanghai (5-Fluorouracil, Cisplatin, Toripalimab)

Recruiting
  • Locoregionally Advanced Laryngo-hypopharyngeal Squamous Cell Cancer
  • 5-Fluorouracil, Cisplatin, Toripalimab
  • Shanghai, China
    Department of Oncology, Ruijin Hospital
Jun 14, 2021

Clinical Stage II HPV-Mediated (p16-pos) Oropharyngeal Carcinoma, Clinical Stage III HPV-Mediated (p16-pos) Oropharyngeal

Not yet recruiting
  • Clinical Stage II HPV-Mediated (p16-pos) Oropharyngeal Carcinoma
  • +15 more
  • Best Practice
  • +9 more
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Aug 23, 2022

Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma, Laryngeal Squamous Cell Carcinoma Trial

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +14 more
  • Biospecimen Collection
  • +9 more
  • (no location specified)
Oct 10, 2023